Trial reportScientific reports2025
A randomized clinical trial of erector spinae plane block and chronic pain after posterior lumbar surgery.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Effect of Intravenous Parecoxib on Early Ambulation After Elective Lumbar Spinal Surgery: A Propensity Score Matching Analysis.Journal of clinical medicine · 2025Article
Corrections and comments
- Retracted
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The effectiveness of erector spinae plane block (ESPB) in preventing chronic pain after posterior lumbar surgery remains controversial. The primary hypothesis of this study was that ESPB reduces the incidence of chronic pain for 3 months after posterior lumbar surgery. In this prospective, randomized, parallel-group study, a total of 120 patients who underwent open posterior lumbar decompression surgery under general anesthesia were randomized into two groups. The ESPB group underwent preoperative bilateral ESPB, and the control group did not receive the block. The primary outcome was the incidence of chronic pain at 3 months after surgery. The secondary outcomes included postoperative morphine consumption, time to first ambulation after surgery, length of hospital stay and incidence of chronic pain at 6 months after surgery. At 3 months, chronic pain was reported in 21/56 (37.5%) and 28/58 (48.3%) patients in the ESPB and control groups, respectively (OR = 1.6; 95% CI, 0.7-3.3; p = 0.245). The ESPB group had less postoperative morphine consumption (p < 0.001) and a shorter time to first ambulation after surgery (p = 0.006) than the control group did. The length of hospital stay was similar. There was also no difference in the incidence of chronic pain at 6 months. ESPB did not reduce the incidence of chronic pain after posterior lumbar surgery, but it did facilitate early recovery after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.